Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-03 4:01 pm Unchanged | 2025-02-27 | 13D | Disc Medicine, Inc. IRON | AI DMI LLC | 3,762,507 10.800% | 0 (Unchanged) | Filing History |
| 2025-02-14 07:50 am Sale | 2024-12-31 | 13G | Disc Medicine, Inc. IRON | Bain Capital Life Sciences Opportunities III, LP | 983,500 3.300% | -812,235 (-45.23%) | Filing History |
| 2025-02-12 09:08 am Sale | 2024-12-31 | 13G | Disc Medicine, Inc. IRON | FMR LLC | 1,866,248 6.300% | -300,571 (-13.87%) | Filing History |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | Disc Medicine, Inc. IRON | Wellington Management Group LLP | 1,395,405 4.700% | -444,821 (-24.17%) | Filing History |
| 2024-11-14 5:44 pm Purchase | 2024-09-30 | 13G | Disc Medicine, Inc. IRON | Bain Capital Life Sciences Opportunities III, LP | 1,795,735 6.000% | 463,190 (+34.76%) | Filing History |
| 2024-11-14 4:33 pm Sale | 2024-09-30 | 13G | Disc Medicine, Inc. IRON | Paradigm Biocapital Advisors LP | 1,497,720 5.040% | -888,137 (-37.23%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Disc Medicine, Inc. IRON | BlackRock Inc. BLK | 1,851,171 6.200% | 0 (Unchanged) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Disc Medicine, Inc. IRON | Wellington Management Group LLP | 1,840,226 6.190% | 1,840,226 (New Position) | Filing History |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Disc Medicine, Inc. IRON | BlackRock Inc. BLK | 1,851,171 6.200% | 1,851,171 (New Position) | Filing History |
| 2024-06-25 10:06 am Purchase | 2024-06-17 | 13G | Disc Medicine, Inc. IRON | Frazier Life Sciences Public Fund, L.P. | 1,754,834 5.900% | 1,754,834 (New Position) | Filing History |
| 2024-06-20 5:15 pm Purchase | 2024-06-17 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 1,785,571 6.000% | 83,334 (+4.90%) | Filing History |
| 2024-06-20 4:01 pm Purchase | 2024-06-17 | 13D | Disc Medicine, Inc. IRON | AI DMI LLC | 3,762,507 12.600% | 416,667 (+12.45%) | Filing History |
| 2024-02-14 4:08 pm Purchase | 2023-12-31 | 13G | Disc Medicine, Inc. IRON | Paradigm Biocapital Advisors LP | 2,385,857 9.900% | 1,149,939 (+93.04%) | Filing History |
| 2024-02-13 6:51 pm Sale | 2023-12-31 | 13G | Disc Medicine, Inc. IRON | Bain Capital Life Sciences Opportunities III, LP | 1,332,545 5.500% | -658,369 (-33.07%) | Filing History |
| 2024-02-09 08:50 am Purchase | 2024-02-08 | 13G | Disc Medicine, Inc. IRON | FMR LLC | 2,166,819 8.975% | 24,095 (+1.12%) | Filing History |
| 2024-02-07 07:24 am Sale | 2023-12-31 | 13G | Disc Medicine, Inc. IRON | ADAGE CAPITAL PARTNERS GP L.L.C. | 750,000 3.110% | -412,624 (-35.49%) | Filing History |
| 2024-01-25 4:38 pm Sale | 2024-01-23 | 13D | Disc Medicine, Inc. IRON | Atlas Venture Fund X L.P. | 1,402,186 5.800% | -191,599 (-12.02%) | Filing History |
| 2023-12-15 4:48 pm Sale | 2023-12-13 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 1,702,237 7.100% | -567,400 (-25.00%) | Filing History |
| 2023-11-13 06:46 am Purchase | 2023-11-09 | 13D | Disc Medicine, Inc. IRON | AI DMI LLC | 3,345,840 13.740% | 204,081 (+6.50%) | Filing History |
| 2023-09-25 4:56 pm Purchase | 2023-09-14 | 13G | Disc Medicine, Inc. IRON | Paradigm Biocapital Advisors LP | 1,235,918 5.400% | 1,235,918 (New Position) | Filing History |